Definium Therapeutics, Inc. (MNMD)
NASDAQ · Healthcare
Definium Therapeutics, Inc. Net Income 2020–2025
Definium Therapeutics, Inc. annual/quarterly net income history and growth rate from 2020 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Definium Therapeutics, Inc. net income for the quarter ending December 31, 2025 was -50.4 M, a 45.18% increase year-over-year.
- Definium Therapeutics, Inc. net income for the twelve months ending December 31, 2025 was -183.8 M.
- Definium Therapeutics, Inc. annual net income for 2025 was -183.8 M, a 69.12% increase from 2024.
- Definium Therapeutics, Inc. annual net income for 2024 was -108.7 M, a 13.52% increase from 2023.
- Definium Therapeutics, Inc. annual net income for 2023 was -95.7 M, a 68.55% increase from 2022.
- Definium Therapeutics, Inc. annual net income for 2022 was -56.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Definium Therapeutics, Inc. Net Income — FAQ
Definium Therapeutics, Inc. (MNMD) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Definium Therapeutics, Inc.'s net income?
Definium Therapeutics, Inc. (MNMD) reported net income of -$184M for fiscal 2025.
Where can I see MNMD's net income history?
The chart and table above show Definium Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.